Overview

Release date: 6/1/2023
Reviewed and renewed: 6/1/2024
Expiration date: 6/1/2025

Activity 1 of the ACMT DEA MATE Act Substance Use Disorder Educational package consists of three separate lectures that were featured at the 2022 and 2023 ACMT Annual Scientific Meetings. All three focus on clinical updates in the treatment of substance use disorder. Check the course syllabus for more info.

Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare. For more info, click here.

CE: 2.75
Length of Activity: ~ 3 hours

Target Audience

All Drug Enforcement Administration (DEA)-registered practitioners who treat patients with opioid or other substance use disorders, including physicians, nurse practitioners, physician assistants, and dentists.This requirement applies to new or renewing DEA registrants.

Learner Objectives

1. Discuss xylazine as an adulterant in drugs of abuse.
2. Describe the pathophysiology of xylazine withdrawal and its management.
3. Recognize the impact of opioid tolerance on achieving adequate analgesia and how MAT for OUD modify opioid requirements.
4. List 3 strategies for the treatment of pain for patients taking buprenorphine including different dosing strategies for buprenorphine.
5. Describe the potential aspects of fentanyl pharmacology contributing to altered responses to buprenorphine initiation.

Commercial Support

There is no commercial support for this activity.

Disclosure of Unlabeled Use and Investigational Product

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.

ACMT DEA MATE Act SUD Education

This course consists of 4 separate activities which satisfy the new, eight-hour education requirement issued by the Drug Enforcement Administration (DEA) to meet the conditions of the MATE Act for all registered practitioners on treating and managing patients with opioid or other substance use disorders. 

• Activity 1: Clinical Updates on Substance Use Disorder (2.75 CR)
• Activity 2: Substance Use Screening and Treatment Approach in the ED – Opioids (1.50 CR)
• Activity 3: Substance Use Screening and Treatment Approach in the ED – Non-Opioids (1.25 CR)
• Activity 4: Highlights from Addiction Toxicology Case Conferences (3.0 CR)

Attendees can register for each activity separately as meets their needs or interest, or sign up for the 4-activity package (a $40 savings!). When taken together, the 4 activities add up to meet the full 8 credits required to maintain DEA licensure.

Syllabus

Total Activity Length: around 3 hours (168 minutes)

X-Factor: Xylazine | 60 min

Matthew S. Salzman, MD, Assistant Professor of Emergency Medicine, Cooper University Health Care, Camden, NJ
Michael Levine, MD, FACMT, Associate Professor, Director of Toxicology, Department of Emergency Medicine, University of California, Los Angeles, CA
Josh Debord, PhD, Senior Scientist, The Center for Forensic Science Research and Education, Willow Grove, PA

In this panel presentation, the speakers discuss Xylazine as an adulterant in drugs of abuse. They describe the pathophysiology of Xylazine-associated soft-tissue infections and discuss Xylazine withdrawal and its management.

Tricks of the Trade: Pain and Perioperative Management in Patients with Opioid Use Disorder | 61 min

JoAn Laes, MD, FACMT, FASAM, Abbott Northwestern Hospital, Allina Health, Minneapolis, MN
Timothy Wiegand, MD, FACMT, FAACT, DFASAM, Associate Professor of Emergency Medicine and the Director of Toxicology and the Toxicology/Addiction Consult Service, Strong Memorial Hospital, University of Rochester Medical Center, Rochester, NY
Katherine Katzung, MD, FASAM, Chair, Emergency Department; Director, Toxicology & Addiction Medicine Program, Abbott Northwestern Hospital, Minneapolis, MN

During this discussion, experts illustrate the impact of opioid tolerance on achieving adequate analgesia and how MAT for OUD modifies opioid requirements. The speakers list strategies for the treatment of pain for patients taking buprenorphine including different dosing strategies. They also describe the standard induction process for buprenorphine and how micro induction protocols differ from the standard induction. This session will include a review of the pathophysiology of precipitated opioid withdrawal and discuss implications for pain control in patients with OUD.

Microdosing and Macrodosing: Alternative Buprenorphine Initiation Strategies in the Fentanyl Era | 47 min

Rachel Haroz, MD, Assistant Professor of Emergency Medicine, Cooper Medical School of Rowan University
Michael Lynch, MD, Medical Director, Pittsburgh Poison Center; Assistant Professor, Division of Medical Toxicology, Department of Emergency Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA
Lewis Nelson, MD, FACMT, Chair of the Department of Emergency Medicine, Rutgers New Jersey Medical School, Newark, NJ
Jeanmarie Perrone, MD, FACMT, Professor of Emergency Medicine at the Hospital of the University of Pennsylvania; Director, Division of Medical Toxicology, Department of Emergency Medicine, University of Pennsylvania, Philadelphia, PA
Rachel S. Wightman, MD, Director of Medical Toxicology Education, Department of Emergency Medicine, Assistant Professor of Emergency Medicine, Alpert Medical School of Brown University, Providence, RI

In this panel discussion, experts describe the potential aspects of fentanyl pharmacology contributing to altered responses to buprenorphine initiation. During their discussion, they address multiple pathways published to initiate Buphrenorphine using very low doses (microdosing) to mitigate risks of adverse reactions or precipitated withdrawal during buprenorphine initiation. They also highlight a parallel option and pharmacology to comprehend a buprenorphine macrodosing approach to mitigate risks of precipitated withdrawal. Lastly, the group discusses the the benefits of buprenorphine telehealth as a low barrier treatment strategy.

Disclosures

None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed for these individuals have been mitigated.

AKH Reviewers and Planners

Dorothy Caputo, MA, BSN, RN, VP, Healthcare Continuing Education and Operations
Bernadette Makar, MSN, APRN-BC, NP-C

Disclosures

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Registration Rates

Registration includes: 

• 90-day access to the course from date of purchase
• 2.75 Continuing Education Credits (Physician, Nurse Practitioner, Physician Assistant or Dentists). For more info, click here.

Interested in becoming an ACMT Member? Contact our Membership Manager at membership@acmt.net. Learn more at: www.acmt.net/membership

Refunds and Cancellations

For questions regarding our refund and cancellation policy, please email us at events@acmt.net.

Package Options - Discounted Rates!

Purchase all 4 ACMT DEA MATE Act Training activities at the same time -- a $40 savings! When packaged together, the 4 activities award 8.50 credits, more than the requirement needed to maintain DEA licensure.

Purchase 4-Activity Package

Instructions

Once you have completed your registration:

1. Click on the Contents tab. This is where you will be able to see all lectures and required content for this course.


2. Watch all recordings. Learners will not be able to fast forward or increase the video speed. Learners will be required to watch at least 3/4 of the video before it will be marked as complete and you can move on to the next. 


3. Complete Post-Test. Learners will have unlimited attempts and the test requires 70% to pass. 


4. Complete Survey. This survey is required by our CE provider and must be completed in full.


5. Download Continuing Education Certificate. Select which certificate to download. Your options are: Physician, Physician Assistant, Nurse Practitioner, or Dental.

Hardware/Software Requirements

Computer or Other Internet-Enabled Device; Internet Connection; Browser. 

Materials

None. 

Prerequisites

None. 

Format

This activity is Web-based/Web on Demand.

Need Assistance or Have Questions?

For assistance logging in, accessing content, purchasing or completing Continuing Education credits, or for other questions, please contact us at events@acmt.net or visit our FAQ page.

If you have questions regarding the CE of this activity, please contact AKH Inc. at JGoldman@akhcme.com.

If you are in need of accessible learning accommodations, please contact events@acmt.net for additional assistance.

Continuing Education

Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare. 

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 2.75 Interprofessional Continuing Education (IPCE) credit for learning and change.

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 2.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.75 AAPA Category 1 CME credits. Approval is valid until June 1, 2025. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT).  AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 2.75 contact hour(s) (which includes 2.5 hour(s) of pharmacology).

Dentists
AKH Inc., Advancing Knowledge in Healthcare is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.

AKH Inc., Advancing Knowledge in Healthcare designates this activity for 2.75 continuing education credits.

Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.

Overview

Release date: 6/1/2023
Reviewed and renewed: 6/1/2024
Expiration date: 6/1/2025

Activity 2 of the ACMT DEA MATE Act Substance Use Disorder Educational package consists of 20-minute or less modules that were originally created for a SAMHSA-funded project called "Frontline: Training Emergency Medicine Residents and Medical Toxicology Fellows to Effectively Screen, Assess, and Treat Patients with Substance Use Disorder." The goal of this project was to provide the same level of training that a Medical Toxicologist might receive on how to provide consultation on SUD patients in the ED to a multidisciplinary emergency department team and staff. The idea being that expanded competency in the ED would result in more cohesive team treatment and better patient outcomes. This activity features highlights from the ACMT SAMHSA curriculum that have a specific focus on opioids. Check the course syllabus for more info.

Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare. For more info, click here.

CE: 1.50
Length of Activity: ~ 2 hours

Target Audience

All Drug Enforcement Administration (DEA)-registered practitioners who treat patients with opioid or other substance use disorders, including physicians, nurse practitioners, physician assistants, and dentists.This requirement applies to new or renewing DEA registrants.

Learner Objectives

1. Contrast aspects of addiction and physical dependence.
2. Identify the best screening and assessment protocol that can be integrated into existing workflows of a busy Emergency Department. 
3. Identify the principles of motivational interviewing. 
4. Describe the pharmacology of Methadone and Naltrexone. 
5. Identify strategies used to beat a urine drug screen and how they can be detected.

Commercial Support

There is no commercial support for this activity.

Disclosure of Unlabeled Use and Investigational Product

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.

ACMT DEA MATE Act SUD Education

This course consists of 4 separate activities which satisfy the new, eight-hour education requirement issued by the Drug Enforcement Administration (DEA) to meet the conditions of the MATE Act for all registered practitioners on treating and managing patients with opioid or other substance use disorders. 

• Activity 1: Clinical Updates on Substance Use Disorder (2.75 CR)
• Activity 2: Substance Use Screening and Treatment Approach in the ED – Opioids (1.50 CR)
• Activity 3: Substance Use Screening and Treatment Approach in the ED – Non-Opioids (1.25 CR)
• Activity 4: Highlights from Addiction Toxicology Case Conferences (3.0 CR)

Attendees can register for each activity separately as meets their needs or interest, or sign up for the 4-activity package (a $40 savings!). When taken together, the 4 activities add up to meet the full 8 credits required to maintain DEA licensure.

Syllabus

Total Activity Length: around 2 hours (110 minutes)

SAMHSA Module: Substance Use Disorder 101: Understanding the Difference Between Addiction and Physical Dependence | 17 min

Kurt Kleinschmidt, MD, FACMT, FASAM, Professor of Emergency Medicine, Division of Medical Toxicology, UT Southwestern Medical Center; Medical Director, Perinatal Intervention Program, Parkland Health and Hospital System, Dallas, TX

In this module, the speaker contrasts aspects of addiction and physical dependence, defines addiction, and determines the disease treated by detoxification.

SAMHSA Module: Screening for and Assessment of Substance Use Disorders in the ED | 19 min

Alaina R. Steck, MD, FACMT, FASAM, Associate Professor of Emergency Medicine, Emory University, Atlanta, GA

In this module, the speaker identifies the best screening and assessment protocol that can be integrated into existing workflows of a busy Emergency Department as well as discusses how to implement universal screening for SUD in Emergency Department patients.

SAMHSA Module: Motivational Interviewing in the ED | 16 min

Henry D. Swoboda, MD, Assistant Professor of Emergency Medicine & Psychiatry, Rush University, Chicago, IL

This module focuses on motivational interviewing, defining its principles and goals.

SAMHSA Module: Methadone | 20 min

Timothy Wiegand, MD, FACMT, FAACT, DFASAM, Associate Professor of Emergency Medicine and the Director of Toxicology and the Toxicology/Addiction Consult Service, Strong Memorial Hospital, University of Rochester Medical Center, Rochester, NY

In this module, the speaker describes important elements related to the history of methadone use for the treatment of opioid use disorder and chronic pain in the United States. He describes the pharmacology of methadone, identifies methadone PEARLS for the Emergency Department, and discusses common medico-legal issues with methadone.

SAMHSA Module: Extended Release Intramuscular Naltrexone in Opioid Use Disorder Treatment | 21 min

Henry D. Swoboda, MD, Assistant Professor of Emergency Medicine, Rush University, Chicago, IL

The speaker in this module focuses on the patient who is a likely candidate for medicated assisted abstinence. He contrasts the risks and benefits of naltrexone compared to other medications and goes through the indications for naltrexone. Lastly, he identifies the common side effects of naltrexone that all healthcare providers should be aware of.

SAMHSA Module: Urine Drug Testing: Interpretation Basics and Pitfalls | 17 min

Rachel S. Wightman, MD, Director of Medical Toxicology Education, Department of Emergency Medicine, Assistant Professor of Emergency Medicine, Alpert Medical School of Brown University, Providence, RI

In this module, the speaker review the advantages and disadvantages of urine screening. She identifies at least two reasons for conducting a urine screen and discusses when a confirmatory test should be conducted. Lastly, she identifies various strategies used to beat a drug screen and how they can be detected.

Disclosures

None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed for these individuals have been mitigated.

AKH Reviewers and Planners

Dorothy Caputo, MA, BSN, RN, VP, Healthcare Continuing Education and Operations
Bernadette Makar, MSN, APRN-BC, NP-C

Disclosures

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Registration Rates

Registration includes: 

• 90-day access to the course from date of purchase
• Continuing Education Credits for: Physicians, Nurse Practitioners, Physician Assistants or Dentists. Click on the "Continuing Education" tab for details. 

The accreditation of this activity is valid until June 1, 2025.

Membership Discount

Interested in becoming an ACMT Member? Contact our Membership Manager at membership@acmt.net. 

Learn more at: www.acmt.net/membership

Refunds and Cancellations

For questions regarding our refund and cancellation policy, please email us at events@acmt.net.

Package Options - Discounted Rates!

Purchase all 4 ACMT DEA MATE Act Education activities at the same time -- a $40 savings! When packaged together, the 4 activities award 8.50 credits, more than the requirement needed to maintain DEA licensure.

Purchase 4-Activity Package

Instructions

Once you have completed your registration:

1. Click on the Contents tab. This is where you will be able to see all lectures and required content for this course.


2. Watch all recordings. Learners will not be able to fast forward or increase the video speed. Learners will be required to watch at least 3/4 of the video before it will be marked as complete and you can move on to the next. 


3. Complete Post-Test. Learners will have unlimited attempts and the test requires 70% to pass. 


4. Complete Survey. This survey is required by our CE provider and must be completed in full.


5. Download Continuing Education Certificate. Select which certificate to download. Your options are: Physician, Physician Assistant, Nurse Practitioner, or Dentist.

Hardware/Software Requirements

Computer or Other Internet-Enabled Device; Internet Connection; Browser. 

Materials

None. 

Prerequisites

None. 

Format

This activity is Web-based/Web on Demand.

Need Assistance or Have Questions?

For assistance logging in, accessing content, purchasing or completing Continuing Education credits, or for other questions, please contact us at events@acmt.net or visit our FAQ page.

If you have questions regarding the CE of this activity, please contact AKH Inc. at JGoldman@akhcme.com.

If you are in need of accessible learning accommodations, please contact events@acmt.net for additional assistance.

Continuing Education

Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare. 

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credit for learning and change.

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until June 1, 2025. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT).  AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 1.5 contact hour(s) (which includes 1.0 hour(s) of pharmacology).

Dentists
AKH Inc., Advancing Knowledge in Healthcare is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.

AKH Inc., Advancing Knowledge in Healthcare designates this activity for 1.5 continuing education credits.

Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.

Overview

Release date: 6/1/2023
Reviewed and renewed: 6/1/2024
Expiration date: 6/1/2025

Activity 3 of the ACMT DEA MATE Act Substance Use Disorder Educational package consists of 5 20-minute or less modules that were originally created for a SAMHSA-funded project called "Frontline: Training Emergency Medicine Residents and Medical Toxicology Fellows to Effectively Screen, Assess, and Treat Patients with Substance Use Disorder." The goal of this project was to provide the same level of training that a Medical Toxicologist might receive on how to provide consultation on SUD patients in the ED to a multidisciplinary emergency department team and staff. The idea being that expanded competency in the ED would result in more cohesive team treatment and better patient outcomes. This activity features highlights from the ACMT SAMHSA curriculum that have a specific focus on non-opioids, for example: stimulants, benzodiazepines, cannabis, and ethanol. Check out the course syllabus for more info.

Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare. For more info, click here.

CE: 1.25
Length of Activity: ~ 1.5 hours

Target Audience

All Drug Enforcement Administration (DEA)-registered practitioners who treat patients with opioid or other substance use disorders, including physicians, nurse practitioners, physician assistants, and dentists.This requirement applies to new or renewing DEA registrants.

Learner Objectives

1. Select potential treatments for stimulant use disorder and the basis for use.
2. Describe the pharmacology of Benzodiazepines and select appropriate management options for Benzodiazepine overdose and withdrawal.
3. Review adverse health events associated with cannabis use and their treatments.
4. Describe characteristics of the alcohol withdrawal syndrome, determine the initial treatment strategy to address alcohol withdrawal, and identify the progression of treatment for resistant alcohol withdrawal treatment.
5. List the available pharmacotherapies of alcohol use disorder.

Commercial Support

There is no commercial support for this activity.

Disclosure of Unlabeled Use and Investigational Product

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.

ACMT DEA MATE Act SUD Education

This course consists of 4 separate activities which satisfy the new, eight-hour education requirement issued by the Drug Enforcement Administration (DEA) to meet the conditions of the MATE Act for all registered practitioners on treating and managing patients with opioid or other substance use disorders. 

• Activity 1: Clinical Updates on Substance Use Disorder (2.75 CR)
• Activity 2: Substance Use Screening and Treatment Approach in the ED – Opioids (1.50 CR)
• Activity 3: Substance Use Screening and Treatment Approach in the ED – Non-Opioids (1.25 CR)
• Activity 4: Highlights from Addiction Toxicology Case Conferences (3.0 CR)

Attendees can register for each activity separately as meets their needs or interest, or sign up for the 4-activity package (a $40 savings!). When taken together, the 4 activities add up to meet the full 8 credits required to maintain DEA licensure.

The training does not have to occur in one session–it can be cumulative across multiple sessions. CE activities listed on this page can be taken in any combination to fulfill the eight-hour requirement.

AKH Partnership

ACMT is partnering with AKH, a trusted source for accredited CE, to offer you two options to satisfy your MATE Act requirement. Choose the format you prefer - on-demand webinars from ACMT or text-based monographs from AKH - and select the hours you need. 

For details, visit AKH at: www.akhcme.com/mate-act

Syllabus

Total Activity Length: around 1.5 hours (95 minutes)

SAMHSA Module: Stimulants | 20 min

Timothy J. Wiegand, MD, FACMT, DFASAM, Director of Toxicology and of the Toxicology Consult Service, University of Rochester Medical Center, Rochester, NY

In this module, the speaker identifies types of stimulants used recreationally, and describes the epidemiology and prevalence of stimulant use disorder. He also discusses the stimulant-related symptoms a patient may present with at the emergency department and matches  potential treatments and basis for use.

SAMHSA Module: Benzodiazepines | 23 min

Rachel Haroz, MD, Assistant Professor of Emergency Medicine, Cooper Medical School of Rowan University, NJ

In this module, the speaker describes the pharmacology of Benzodiazepines, and identifies the signs of Benzodiazepine overdose and withdrawal. She review appropriate management options for Benzodiazepine overdose and withdrawal and identifies tapering options. She also discusses the limitations of diagnostic urine testing.

SAMHSA Module: Cannabis (THC) | 18 min

Evan Schwarz, MD, FACMT, Associate Professor of Emergency Medicine, University of California, Los Angeles, CA

This module reviews adolescent attitudes regarding use of cannabis before and after changes in legal status. The speaker discusses the impact of the changing legal status of cannabis on pediatric exposures and reviews adverse health events associated with cannabis use and their treatments.

SAMHSA Module: Ethanol Withdrawal | 17 min

Lewis Nelson, MD, FACMT, Chair of the Department of Emergency Medicine, Rutgers New Jersey Medical School, Newark, NJ

The speaker in this module describes characteristics of the alcohol withdrawal syndrome, identifying related causes of death. He describe initial treatment strategies to address alcohol withdrawal, and goes through the progression of treatment for resistant alcohol withdrawal treatment. Lastly, he explains the role of adjunctive medications in alcohol withdrawal syndrome.

SAMHSA Module: Therapies to Maintain Sobriety from Alcohol | 17 min

JoAn Laes, MD, FACMT, FASAM, Abbott Northwestern Hospital, Allina Health, Minneapolis, MN

In this module, the speaker lists the available pharmacotherapies of alcohol use disorder, and identifies the proper dose for at least one of the AUD pharmacotherapies. She reviews the six dimensions of ASAM levels of care and covers how to select referral options for treatment of patients with alcohol use disorder.

Disclosures

None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed for these individuals have been mitigated.

AKH Reviewers and Planners

Dorothy Caputo, MA, BSN, RN, VP, Healthcare Continuing Education and Operations
Bernadette Makar, MSN, APRN-BC, NP-C

Disclosures

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Registration Rates

Registration includes: 

• 90-day access to the course from date of purchase


• Continuing Education Credits for: Physicians, Nurse Practitioners, Physician Assistants or Dentists. Click on the "Continuing Education" tab for details. 

The accreditation of this activity is valid until June 1, 2024.

Membership Discount

Interested in becoming an ACMT Member? Contact our Membership Manager at membership@acmt.net. 

Learn more at: www.acmt.net/membership

Refunds and Cancellations

For questions regarding our refund and cancellation policy, please email us at events@acmt.net.

Package Options - Discounted Rates!

Purchase all 4 ACMT DEA MATE Act Education activities at the same time -- a $40 savings! When packaged together, the 4 activities award 8.50 credits, more than the requirement needed to maintain DEA licensure.

Purchase 4-Activity Package

Instructions

Once you have completed your registration:

1. Click on the Contents tab. This is where you will be able to see all lectures and required content for this course.


2. Watch all recordings. Learners will not be able to fast forward or increase the video speed. Learners will be required to watch at least 3/4 of the video before it will be marked as complete and you can move on to the next. 


3. Complete Post-Test. Learners will have unlimited attempts and the test requires 70% to pass. 


4. Complete Survey. This survey is required by our CE provider and must be completed in full.


5. Download Continuing Education Certificate. Select which certificate to download. Your options are: Physician, Physician Assistant, Nurse Practitioner, or Dentist.

Hardware/Software Requirements

Computer or Other Internet-Enabled Device; Internet Connection; Browser. 

Materials

None. 

Prerequisites

None. 

Format

This activity is Web-based/Web on Demand.

Need Assistance or Have Questions?

For assistance logging in, accessing content, purchasing or completing Continuing Education credits, or for other questions, please contact us at events@acmt.net or visit our FAQ page.

If you have questions regarding the CE of this activity, please contact AKH Inc. at JGoldman@akhcme.com.

If you are in need of accessible learning accommodations, please contact events@acmt.net for additional assistance.

Continuing Education

Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare. 

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME credits. Approval is valid until June 1, 2024. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT).  AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 1.25 contact hour(s) (which includes 1.0 hour(s) of pharmacology).

Dentists
AKH Inc., Advancing Knowledge in Healthcare is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.

AKH Inc., Advancing Knowledge in Healthcare designates this activity for 1.25 continuing education credits.

Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.

Overview

Release date: 6/1/2023
Reviewed and renewed: 6/1/2024
Expiration date: 6/1/2025

Activity 4 of the ACMT DEA MATE Act Substance Use Disorder Educational package consists of three 60-minute highlights from the ACMT/ASAM Addiction Toxicology Case Conference webinar series. This webinar series features experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology discussing cases in an interactive fashion. The case-based discussions focuse on such subjects as overdose prevention field work, kratom, cannabis, and alcohol use disorder. Check out the course syllabus for more info.

Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare. For more info, click here.

CE: 3.0
Length of Activity: 3 hours

Target Audience

All Drug Enforcement Administration (DEA)-registered practitioners who treat patients with opioid or other substance use disorders, including physicians, nurse practitioners, physician assistants, and dentists.This requirement applies to new or renewing DEA registrants.

Learner Objectives

1. Describe the basic resources found in an overdose prevention site.
2. Identify the pharmacology of Kratom.
3. Review pediatric cannabis ingestion trends in the United States.

Commercial Support

There is no commercial support for this activity.

Disclosure of Unlabeled Use and Investigational Product

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.

ACMT DEA MATE Act SUD Education

This course consists of 4 separate activities which satisfy the new, eight-hour education requirement issued by the Drug Enforcement Administration (DEA) to meet the conditions of the MATE Act for all registered practitioners on treating and managing patients with opioid or other substance use disorders. 

• Activity 1: Clinical Updates on Substance Use Disorder (2.75 CR)
• Activity 2: Substance Use Screening and Treatment Approach in the ED – Opioids (1.50 CR)
• Activity 3: Substance Use Screening and Treatment Approach in the ED – Non-Opioids (1.25 CR)
• Activity 4: Highlights from Addiction Toxicology Case Conferences (3.0 CR)

Attendees can register for each activity separately as meets their needs or interest, or sign up for the 4-activity package (a $40 savings!). When taken together, the 4 activities add up to meet the full 8 credits required to maintain DEA licensure.

The training does not have to occur in one session–it can be cumulative across multiple sessions. CE activities listed on this page can be taken in any combination to fulfill the eight-hour requirement.

AKH Partnership

ACMT is partnering with AKH, a trusted source for accredited CE, to offer you two options to satisfy your MATE Act requirement. Choose the format you prefer - on-demand webinars from ACMT or text-based monographs from AKH - and select the hours you need. 

For details, visit AKH at: www.akhcme.com/mate-act

Syllabus

Total Activity Length: 3 hours (180 minutes)

ACMT/ASAM Addiction Toxicology Case Conference: Safe Consumption/OD Prevention Sites Field Work and Perspectives (May 2023) | 60 min

Timothy J. Wiegand, MD, FACMT, DFASAM, Director of Toxicology and of the Toxicology Consult Service, University of Rochester Medical Center, Rochester, NY
Gloria J. Baciewicz, MD, Addiction Psycharcist, Strong Recovery; Professor of Clinical Psychiatry, Department of Psychiatry, University of Rochester Medical Center, Rochester, NY
Daniel Ciccarone, MD, MPH, Justine Miner Professor of Addiction Medicine, Family and Community Medicine, UCSF, San Francisco, CA
Ross Sullivan, MD, FACMT, FASAM, Medical Director, Helio Health; Associate Professor of Emergency Medicine, Medical Toxicologist & Addiction Medicine, SUNY Upstate Medical University, Syracuse, NY
Paul Updyke, MD, Medical Director, Pathways; Addiction Medicine Specialist and Family Medicine Specialist, Buffalo NY

During this case-based discussion, the panelists list harm reduction techniques associated with injection drug use. They then review harm reduction techniques associated with smoke drugs, and describe the basic resources found in an overdose prevention site.

ACMT/ASAM Addiction Toxicology Case Conference: Kratom (October 2022) | 60 min

Timothy J. Wiegand, MD, FACMT, DFASAM, Director of Toxicology and of the Toxicology Consult Service, University of Rochester Medical Center, Rochester, NY
Gloria J. Baciewicz, MD, Addiction Psycharcist, Strong Recovery; Professor of Clinical Psychiatry, Department of Psychiatry, University of Rochester Medical Center, Rochester, NY
Katherine Katzung, MD, FASAM, Chair, Emergency Department; Director, Toxicology & Addiction Medicine Program, Abbott Northwestern Hospital, Minneapolis, MN
JoAn Laes, MD, FACMT, FASAM, Abbott Northwestern Hospital, Allina Health, Minneapolis, MN
Parth Patel, DO, Resident, Emergency Medicine, Arnot Ogden Medical Center, Elmira, NY
Zachary Reed, DO, Resident, Emergency Medicine, Arnot Ogden Medical Center, Elmira, NY

During this discussion, panelists describe the pharmacology of Kratom and review why people may use Kratom.

ACMT/ASAM Addiction Toxicology Case Conference: Discussion of Pediatric Cannabis Ingestions and a Case Involving a Patient Admitted to a Research Unit (January 2023) | 60 min

Timothy J. Wiegand, MD, FACMT, DFASAM (ACMT/ASAM Expert), Director of Toxicology and of the Toxicology Consult Service, University of Rochester Medical Center, Rochester, NY 
Gloria J. Baciewicz, MD, Addiction Psychiatrist, Strong Recovery; Professor of Clinical Psychiatry, Department of Psychiatry, University of Rochester Medical Center, Rochester, NY
Jeffrey Brent, MD, PhD, FACMT, Distinguished Clinical Professor of Medicine and Emergency Medicine, University of Colorado Schools of Medicine and Public Health, Denver, CO
Stephanie T. Weiss, MD, PhD, Staff Research Physician, Translational Addiction Medicine Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Washington, DC

During this case-based discussion, the panelists explore the topic of pediatric cannabis ingestion trends and review a recent case. The then discuss a case in which an Alcohol Use Disorder (AUD) inpatient study participant develops altered mental status the week after admission to a locked clinical research unit.

Disclosures

None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed for these individuals have been mitigated.

AKH Reviewers and Planners

Dorothy Caputo, MA, BSN, RN, VP, Healthcare Continuing Education and Operations
Bernadette Makar, MSN, APRN-BC, NP-C

Disclosures

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Registration Rates

Registration includes: 

• 90-day access to the course from date of purchase
• Continuing Education Credits for: Physicians, Nurse Practitioners, Physician Assistants or Dentists. Click on the "Continuing Education" tab for details. 

The accreditation of this activity is valid until June 1, 2025.

Membership Discount

Interested in becoming an ACMT Member? Contact our Membership Manager at membership@acmt.net. 

Learn more at: www.acmt.net/membership

Refunds and Cancellations

For questions regarding our refund and cancellation policy, please email us at events@acmt.net.

Package Options - Discounted Rates!

Purchase all 4 ACMT DEA MATE Act Education activities at the same time -- a $40 savings! When packaged together, the 4 activities award 8.50 credits, more than the requirement needed to maintain DEA licensure.

Purchase 4-Activity Package

Instructions

Once you have completed your registration:

1. Click on the Contents tab. This is where you will be able to see all lectures and required content for this course.
2. Watch all recordings. Learners will not be able to fast forward or increase the video speed. Learners will be required to watch at least 3/4 of the video before it will be marked as complete and you can move on to the next. 
3. Complete Post-Test. Learners will have unlimited attempts and the test requires 70% to pass. 
4. Complete Survey. This survey is required by our CE provider and must be completed in full.
5. Download Continuing Education Certificate. Select which certificate to download. Your options are: Physician, Physician Assistant, Nurse Practitioner, or Dentist.

Hardware/Software Requirements

Computer or Other Internet-Enabled Device; Internet Connection; Browser. 

Materials

None. 

Prerequisites

None. 

Format

This activity is Web-based/Web on Demand.

Need Assistance or Have Questions?

For assistance logging in, accessing content, purchasing or completing Continuing Education credits, or for other questions, please contact us at events@acmt.net or visit our FAQ page.

If you have questions regarding the CE of this activity, please contact AKH Inc. at JGoldman@akhcme.com.

If you are in need of accessible learning accommodations, please contact events@acmt.net for additional assistance.

Continuing Education

Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare. 

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 3.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 3.0 AAPA Category 1 CME credits. Approval is valid until June 1, 2025. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT).  AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 3.0 contact hour(s) (which includes 2.5 hour(s) of pharmacology).

Dentists
AKH Inc., Advancing Knowledge in Healthcare is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.

AKH Inc., Advancing Knowledge in Healthcare designates this activity for 3.0 continuing education credits.

Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.